The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Boston Trust Walden Corp

Boston Trust Walden Corp boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.5% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,253,815 shares of the medical device company’s stock after acquiring an additional 19,038 shares during the period. Cooper Companies makes up approximately 1.0% of Boston Trust Walden Corp’s portfolio, making the stock its 15th largest position. Boston Trust Walden Corp’s holdings in Cooper Companies were worth $138,346,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. grew its position in shares of Cooper Companies by 248.6% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after acquiring an additional 174 shares during the period. Covestor Ltd boosted its position in Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares in the last quarter. Innealta Capital LLC acquired a new stake in Cooper Companies in the second quarter valued at approximately $25,000. Crewe Advisors LLC increased its position in shares of Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares in the last quarter. Finally, Clearstead Trust LLC acquired a new position in shares of Cooper Companies during the 1st quarter worth approximately $36,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.5 %

NASDAQ COO traded up $0.52 on Friday, reaching $107.82. The stock had a trading volume of 3,270,373 shares, compared to its average volume of 1,128,228. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average price of $105.73 and a two-hundred day moving average price of $96.72. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The firm has a market capitalization of $21.47 billion, a price-to-earnings ratio of 63.42, a P/E/G ratio of 2.56 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 EPS. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on COO. Robert W. Baird lifted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and lifted their target price for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Wells Fargo & Company upped their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Morgan Stanley raised their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $115.00.

Insider Activity at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at $520,488.54. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.